Skip to main content
OpenTrials

Clinical trial condition

Colorectal Neoplasms

Explore clinical trials studying Colorectal Neoplasms. Study availability and eligibility vary by location and protocol.

4,249 public trials 881 recruiting studies
Refine in advanced search Browse all conditions

Colorectal Neoplasms trial results

Completed

Colorectal Cancer Screening Assessment Study

NCT04500171

Conditions
Colonic Diseases, Colorectal Cancer, Colorectal Neoplasms, +9 more
Locations
  • American Samoa Community Cancer Coalition Pago Pago, American Samoa
  • American Samoa Power Authority Abe Malae Operations Center Tafuna, American Samoa
View Trial Details
Completed

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

NCT02279433

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +23 more
Locations
  • HonorHealth Research Institute Scottsdale, Arizona, United States
  • Chao Family Comprehensive Cancer Center of Orange, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Inst. Boston, Massachusetts, United States
View Trial Details
Completed

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

NCT02368886

Conditions
Colon Adenocarcinoma, Colonic Diseases, Colonic Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Illinois CancerCare-Peoria Peoria, Illinois, United States
View all 22 locations
View Trial Details
Completed

A Study of CDX-585 in Patients With Advanced Malignancies

NCT05788484

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Urothelial Carcinoma, +64 more
Locations
  • George Washington University Cancer Center Washington D.C., District of Columbia, United States
  • AdventHealth Celebration Celebration, Florida, United States
  • Perlmutter Cancer Center at NYU Langone Health New York, United States
  • Providence Cancer Institute Portland, Oregon, United States
View Trial Details
Completed

Study of NKTR 255 in Combination With Cetuximab in Solid Tumors

NCT04616196

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +16 more
Locations
  • University of California, San Diego San Diego, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Minnesota Minneapolis, Minnesota, United States
  • Mary Crowley Cancer Research Dallas, Texas, United States
View Trial Details
Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • UC Irvine Medical Center Orange, California, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
View all 71 locations
View Trial Details

Related conditions